SUNWIN STEVIA INTERNATIONAL, INC.
SUNWIN STEVIA INTERNATIONAL, INC. (SUWN): 1 pipeline candidate · ~15 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
14.7 months
D/E 3.54 · 316% dilution
Lead: Approved
1 candidate
N/A
N/A
A transparent, data-derived signal for SUNWIN STEVIA INTERNATIONAL, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$2.8M
Quarterly Burn
$1.4M
Runway
14.7 mo
Revenue
$7.4M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| steviosin | Approved |
Frequently asked questions
How many drug candidates are in SUNWIN STEVIA INTERNATIONAL, INC.'s pipeline?
SUNWIN STEVIA INTERNATIONAL, INC. (SUWN) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is SUNWIN STEVIA INTERNATIONAL, INC.'s lead drug candidate?
SUNWIN STEVIA INTERNATIONAL, INC.'s most advanced tracked candidate is steviosin (Approved) for medicinal use.
What is SUNWIN STEVIA INTERNATIONAL, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, SUNWIN STEVIA INTERNATIONAL, INC. has approximately 14.7 months of cash runway.
Get the full picture on SUNWIN STEVIA INTERNATIONAL, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.